HOUSTON--(BUSINESS WIRE)--HealthHelp, a leader in specialty benefits management, welcomes Dr. Cindy Ippoliti to the position of Oncology Pharmacy Consultant. Dr. Ippoliti brings with her 25 years in the field of oncology pharmacy practice and research.
HealthHelp leads the way in oncology benefit management through its innovative, consultative, non-denial model that allows the ordering physicians access to best-in-class, evidence-based clinical guidelines, and a collaborative peer-to-peer consultation with top oncologists in the country.
The addition of Ippoliti’s vast knowledge fits directly in line with HealthHelp’s mission to move healthcare forward into the next century. Ippoliti is highly regarded in her field for broadening the oncology programs at many esteemed hospitals and research centers, including M.D. Anderson’s renowned Cancer Center, New York Presbyterian Hospital Cornell Medical Center, among others.
HealthHelp’s innovative, patient-focused oncology services were added to ensure that cancer patients receive only the necessary medical procedures and therapeutic regimens. This is achieved through the continuous evaluation and adaptation of the most current clinical oncology practices. In this rapidly changing field, Dr. Ippoliti brings to HealthHelp a unique ability to keep the company’s scholarship moving as quickly as possible, keeping pace with any new developments in evidence-based medicine and therapeutics, patient treatments and cost-savings methodologies.
When HealthHelp’s Chief Executive Officer, Cherrill Farnsworth, reviewed Dr. Ippoliti’s impressive history in the field, she knew the doctor would be an excellent addition to the team.
“At HealthHelp, keeping abreast of the latest medical technology is vital—for us and for our clients,” says Farnsworth. “Bringing Cindy on board was a strategic move for the company to further our knowledge-base in the field of oncological pharmaceuticals. We are thrilled to have Cindy’s expertise.”
Dr. Ippoliti will work directly alongside HealthHelp’s management team, Mark Tankersley PhD, Dr. Tony DeFrance, and Dr. Ira Braunschweig, to enhance the oncology program for oncology drug management to provide safe and sound drug treatments for HealthHelp’s clients. Additionally, she will move forward the company’s outcomes research for publication.
Dr. Ippoliti’s research is unrivaled and has been published in numerous respected medical journals, translated into both English and Turkish. She has shared her work nationally at hospitals and medical symposiums, which is why HealthHelp’s Medical Director of Oncology Dr. Braunschweig solicited her for the position.
"Dr. Ippoliti is truly an innovator in the field of medical oncology,” says Dr. Braunschweig. “She was at the University of Texas, M.D. Anderson Cancer Center for many years, where she was instrumental in growing their stem cell transplant program into one of the premier programs in the country. We look forward to benefiting from her expertise and vision, as we continue to bolster our quality program here at HealthHelp."
“Clinical pharmacy patient management and health outcomes research have a large impact on quality patient care. Dr. Ippoliti has many years of experience as well as advanced training and continues to teach in a clinical residency training program. She brings great clinical patient management strength to our team and also adds to our expert bandwidth for producing high quality health outcomes for our payor partners and their membership. These strengths will help us move healthcare forward in the medical oncology realm. We are excited to have her join the team,” says Mark Tankersley PHD, HealthHelp’s Director of Medical Economics and Outcomes Research. In addition, Dr. Tony DeFrance, HealthHelp’s Chief Medical Officer, touts Dr. Ippoliti as a highly respected name in the field of oncology.
“HealthHelp has always sought the highest levels of clinical professionals for its team, which is why we are so excited about bringing Dr. Ippoliti aboard. Dr. Ippoliti will help us continue to improve the quality of HealthHelp’s oncology programs and outcomes,” says Dr. DeFrance.
About HealthHelp®
HealthHelp, a leader in specialty benefits management, generates significant savings and return on investment for health care payors by enhancing physician knowledge, improving quality of care, and reducing unnecessary radiation exposure and inappropriate oncology use of chemotherapeutic regiments Each of its programs addresses a different aspect of oncology, cardiology, radiology, emergency medicine, spinal surgery and pain management, and sleep care. The clients of Houston-based HealthHelp administer local, statewide, and national health care plans across the country. For more information about HealthHelp’s programs, visit http://www.healthhelp.com/specialties/.
